• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

    4/23/25 5:15:00 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    • REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAR
    • OPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAR
    • OPERATING MARGINS, EX-ITEMS, OF 10%
    • GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEAR
    • FREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR
    • NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31
    • COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION
    • COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND

    HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,600,000. Core's operating income was $4,400,000, with earnings per diluted share ("EPS") of $0.00, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $11,800,000, yielding operating margins of 10%, and EPS, ex-items, of $0.14. During the first quarter of 2025, the Company recorded an adjustment of approximately $6,900,000 associated with employee severance, facility consolidation expenses, and non-cash stock compensation expense. Additionally, income tax expense for the first quarter of 2025 includes several discrete tax adjustments. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

    Core's CEO, Larry Bruno stated, "In addition to the normal seasonal decline in client activity that typically occurs between the fourth and first quarters, Core Lab's team navigated a volatile market that included complications due to external factors associated with ongoing geopolitical conflicts, the announcement of expanded sanctions, and pending tariffs. These political headwinds impacted demand for our laboratory services tied to the maritime transportation and trading of crude oil and derived products, and also interfered with some perforating product sales. These factors created temporary operational inefficiencies for the Company.

    During the first quarter, Core Lab engaged with a number of new clients to pursue growth opportunities in the Middle East and Africa, two regions that we see as long-term growth drivers for our products and services. Core's face-to-face meetings with operators in the Asia-Pacific region during the first quarter reinforced Core Lab's role in upcoming exploration and development programs. Our growing worldwide client base values the innovative solutions we provide, and which help them address the complex challenges of the global energy market. Core's technological expertise and constant client engagement will drive long-term results for our shareholders."

    Reservoir Description

    Reservoir Description operations are closely correlated with trends in international and offshore activity levels, with approximately 80% of revenue sourced from projects originating outside the U.S. Revenue in the first quarter of 2025 was $80,900,000, down 7% sequentially, and 4% from last year. Operating income on a GAAP basis was $2,300,000, while operating income, ex-items, was $7,800,000, yielding operating margins of 10%. The segment's financial performance in the first quarter was adversely impacted by: 1) typical seasonal patterns, 2) international geopolitical conflicts, 3) recently expanded sanctions, and 4) pending tariffs. The geopolitical factors created volatility in commodity prices, which, in turn, negatively impacted first quarter demand for laboratory services tied to the maritime transportation and trade of crude oil and derived products. Demand for these assay services did improve late in the quarter.

    Emerging unconventional plays continue to hold significant strategic importance for the future production plans of operators across the Middle East. Various published sources suggest that unconventional reservoirs across the Arabian Peninsula contain proven reserves in excess of 300 billion barrels of oil and 750 trillion cubic feet of natural gas. Core Lab is partnering with National Oil Companies ("NOCs") and independent operators across the region to evaluate these assets. In the first quarter of 2025, to better understand the reservoir rock and fluid properties of an unconventional play in the region, Core Lab was engaged by a leading NOC in the first quarter of 2025 to execute a comprehensive multi-well study. The analytical program employed Core's proprietary laboratory technologies, including the Company's innovative PRISM™ workflow. The PRISM™ analytical package integrates a variety of technologies, such as reservoir condition, high-frequency, Nuclear Magnetic Resonance ("NMR"). The analytical results delivered critical insights into fluid saturation profiles across these unconventional reservoirs and, very importantly, delineated the mobility potential of the various hydrocarbon phases. Core Lab's data will provide key inputs for the client's reservoir model and development strategies. Data generated by Core are securely stored and delivered to the client through the Company's proprietary data management platform, RAPID™, ensuring robust data integrity and a highly efficient client experience for engineers, geoscientists, and petrophysicists.

    Production Enhancement

    Production Enhancement operations, which are focused on complex completions in unconventional oil and gas reservoirs in the U.S., as well as conventional and unconventional projects across the globe, posted first quarter 2025 revenue of $42,700,000, flat sequentially and down 6% year-over-year. Operating income on a GAAP basis was $1,500,000, while operating income, ex-items, was $3,400,000, yielding operating margins of 8%, a sequential margin improvement of 450 basis points. Production Enhancement revenue was flat sequentially, despite an estimated 10% decrease in the U.S. land frac spread. Improved profitability was largely driven by increased demand for diagnostic services in the U.S., both onshore and offshore. Core's diagnostic service revenue continues to improve as U.S. completion designs become ever more complex. This growth, along with improved U.S. product sales, was offset by a decline in international product sales for the quarter.

    During the first quarter of 2025, Core Lab's Production Enhancement segment utilized its state-of-the-art product testing facility to engineer a remedy for potential stuck drill pipe on an offshore project in the Middle East. The operator saw considerable risk should the need arise to cut the heavy gauge drill pipe required for this project. With no suitable mechanical milling options available, the client engaged the Company to test a ballistic solution using Core Lab's proprietary DCST™ drill collar severing tool. Core's DCST™ is designed for efficient pipe recovery operations, particularly when conventional drill pipe and casing cutters cannot be used. The DCST™ works by using precisely-timed energetic events that are sequenced to create two equal and opposing shock fronts, focusing the energy outward, and severing the drill collar or heavy pipe. The tests, performed under simulated downhole conditions, confirmed the effectiveness of the DCST™, providing the operator with a solution should they encounter stuck heavy gauge drill pipe. This allowed the operator to continue using existing equipment and materials, while still having a cost-effective remediation option. 

    Also in the first quarter of 2025, a U.S. operator engaged Core Lab's Diagnostics team to deploy the Company's suite of HT Profiler™ extreme high temperature water tracers, to evaluate a multi-stage geothermal well injection program, with bottomhole temperatures in excess of 570˚F. Geothermal projects often involve the creation of a hydraulic connection between injector and producer wells. This creates a flow loop through which naturally heated water is returned to the surface. To validate these high temperature water tracers, the well was shut-in for over a month prior to flowback. Analysis of the flowback fluids confirmed long-term tracer stability at these extreme conditions. Core's HT Profiler™ extreme high temperature water tracers enable geothermal operators to develop vector maps for water injection programs that delineate subsurface flow patterns and aid in the optimization of geothermal projects. Core Lab's engagement on this project is ongoing.

    Liquidity, Free Cash Flow, Share Repurchases, and Dividend

    Core continues to focus on maximizing free cash flow ("FCF"), a non-GAAP financial measure defined as cash from operations less capital expenditures. For the first quarter of 2025, cash from operations was $6,700,000 and capital expenditures associated with operations were $2,800,000, yielding FCF of $3,900,000. Cash from operations was impacted by an increase in working capital, as accounts receivable grew by $5,300,000 during the quarter. The growth in accounts receivable occurred in March, reflecting a higher level of sales at quarter-end. In February 2024, fire damaged one building on the campus of the Company's Advanced Technology Center in Aberdeen, Scotland. Losses and damage caused by the fire are covered by the Core Lab's insurance programs. The insurance proceeds, and the capital expenditures associated with replacing the equipment and restoring the building, are disclosed separately in the investing section of the cash flow statement. These items are not included in the calculation of FCF.

    As of March 31, 2025, Core's net debt (defined as long-term debt less cash and cash equivalents) was $103,900,000, which was reduced by $4,900,000 during the quarter. Also during the first quarter of 2025, the Company's leverage ratio (calculated as total net debt divided by trailing twelve months adjusted EBITDA) of 1.31, flat compared to December 31, 2024, and remained at the lowest level in eight years.

    The Company will remain focused on executing its strategic business initiatives while also further reducing its leverage ratio. In addition, Core Lab will continue to evaluate allocation of capital and other uses of free cash to return value to shareholders.

    On January 29, 2025, Core's Board of Directors ("Board") announced a quarterly cash dividend of $0.01 per share of common stock, which was paid on March 3, 2025, to shareholders of record on February 10, 2025.

    On April 23, 2025, the Board approved a cash dividend of $0.01 per share of common stock payable on May 27, 2025, to shareholders of record on May 5, 2025. 

    Return On Invested Capital

    The Board and the Company's Executive Management continue to focus on strategies that maximize return on invested capital ("ROIC") and FCF, factors that have high correlation to total shareholder return. Core's commitment to an asset-light business model and disciplined capital stewardship promote capital efficiency and are designed to produce more predictable and superior long-term ROIC.

    The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg, as the Company continues to believe superior ROIC will result in higher total shareholder return. Using Bloomberg's formula, the Company's ROIC for the first quarter of 2025 was 8.3%.

    Industry and Core Lab Outlook and Guidance

    Recent tariffs announced by the U.S., along with OPEC's decision to increase oil production, have resulted in a decline in crude oil prices. The uncertainty of demand for crude oil caused by ongoing trade negotiations, combined with the OPEC+ announcement of increased production quotas, has raised the likelihood that crude oil inventory levels will rise. Core maintains its constructive long-term outlook on international upstream projects for the remainder of 2025 and beyond. The IEA, EIA, and OPEC+ continue to forecast growth in crude oil demand to be between 0.7 and 1.3 million barrels per day for 2025. This demand is mainly driven by non-OECD countries in Asia, India, emerging markets in the Middle East, and Africa. Outside the U.S., large-scale international oil and gas projects are expected to be more resilient to the near-term volatility of crude oil prices.

    Core sees international project activity to be steady, with committed long-term upstream projects from the South Atlantic Margin, North and West Africa, Norway, the Middle East, and certain areas of Asia Pacific. The Company believes that activity levels associated with smaller-scale, short-cycle crude oil development projects will be more sensitive to a decrease and/or continued volatility of crude oil prices. As such, changes in crude oil prices are anticipated to have a greater impact on drilling and completion activity levels in the U.S. onshore market.

    Core Lab believes that the proposed tariffs will not apply to the vast majority of service revenue and product sales provided by the Company. Core Lab's services account for over 75% of the Company's total revenue, and are currently not subject to tariffs. Core's product sales have been less than 25% of total revenue, and are primarily manufactured in the U.S.; import tariffs would not apply to approximately 50% of these products, as they are consumed in the U.S. drilling and completion markets. Products manufactured in the U.S. and delivered to international clients may attract tariffs depending on the outcome of international trade negotiations. Certain raw materials imported and used in the Company's U.S manufacturing of products may attract import tariffs applied by the U.S. The Company is currently taking steps to mitigate the impact of potential tariffs.

    Reservoir Description's second quarter revenue is projected to range from $85,000,000 to $89,000,000, and operating income of $11,000,000 to $13,000,000. Production Enhancement's second quarter revenue is estimated to range from $43,000,000 to $45,000,000, with operating income of $2,000,000 to $2,600,000.

    Core's second quarter 2025 revenue is projected to range from $128,000,000 to $134,000,000, with operating income of $13,100,000 to $15,700,000, yielding operating margins of approximately 11%. EPS for the second quarter of 2025 is expected to be $0.17 to $0.21. 

    The Company's second quarter 2025 guidance is based on projections for underlying operations and excludes gains and losses in foreign exchange. Although the first quarter of 2025 includes discrete items which increased the effective tax rate, the Company projects the effective tax rate for 2025 to be approximately 25%. Second quarter guidance assumes an effective tax rate of 25%.

    Earnings Call Scheduled

    The Company has scheduled a conference call to discuss Core's first quarter 2025 earnings announcement. The call will begin at 7:30 a.m. CDT / 8:30 a.m. EDT on Thursday, April 24, 2025.  To register for the listen-only webcast, log on to www.corelab.com 15 minutes before the start of the call. For those not available to listen to the live webcast, a replay and transcript will be available on the Company's website shortly after the call. Analysts may contact [email protected] for conference call dial-in information.

    Core Laboratories Inc. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more than 50 countries and is located in every major oil-producing province in the world. This release, as well as other statements Core Lab makes, includes forward-looking statements regarding the Company's future revenue, profitability, business strategies and developments, demand for the Company's products and services and for products and services of the oil and gas industry generally, made in reliance upon the safe harbor provisions of Federal securities law. The Company's outlook is subject to various important cautionary factors, including risks and uncertainties related to the oil and natural gas industry, business and general economic conditions, including inflationary pressures, the impact on tariffs and sanctions, international markets, international political climates, including the Russia-Ukraine and the Middle East geopolitical conflicts, public health crises, and any related actions taken by businesses and governments, and other factors as more fully described in the Company's most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. These important factors could cause the Company's actual results to differ materially from those described in these forward-looking statements. Such statements are based on current expectations of the Company's performance and are subject to a variety of factors, some of which are not under the control of the Company. Because the information herein is based solely on data currently available, and because it is subject to change as a result of changes in conditions over which the Company has no control or influence, such forward-looking statements should not be viewed as assurance regarding the Company's future performance.

    The Company undertakes no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances that may arise after the date of this press release, except as required by law.

    Visit the Company's website at www.corelab.com.

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share data)

    (Unaudited)

     





    Three Months Ended





    % Variance





    March 31,

    2025





    December 31,

    2024





    March 31,

    2024





    vs. Q4-24



    vs. Q1-24

    REVENUE



    $

    123,585





    $

    129,237





    $

    129,637





    (4.4) %



    (4.7) %





























    OPERATING EXPENSES:



























    Costs of services and product sales





    99,469







    106,199







    104,588





    (6.3) %



    (4.9) %

    General and administrative expense





    13,647







    9,080







    11,789





    50.3 %



    15.8 %

    Depreciation and amortization





    3,717







    3,664







    3,843





    1.4 %



    (3.3) %

    Other (income) expense, net





    2,335







    (3,880)







    846





    NM



    176.0 %

    Total operating expenses





    119,168







    115,063







    121,066





    3.6 %



    (1.6) %





























    OPERATING INCOME





    4,417







    14,174







    8,571





    (68.8) %



    (48.5) %

    Interest expense





    2,602







    2,629







    3,423





    (1.0) %



    (24.0) %

    Income before income taxes





    1,815







    11,545







    5,148





    (84.3) %



    (64.7) %

    Income tax expense





    1,746







    4,076







    1,658





    (57.2) %



    5.3 %

    Net income





    69







    7,469







    3,490





    (99.1) %



    (98.0) %

    Net income attributable to non-controlling interest





    223







    66







    270





    NM



    NM

    Net income (loss) attributable to Core Laboratories Inc.



    $

    (154)





    $

    7,403





    $

    3,220





    NM



    NM





























    Diluted earnings per share



    $

    —





    $

    0.16





    $

    0.07





    NM



    NM





























    Diluted earnings (loss) per share attributable to Core Laboratories Inc.



    $

    —





    $

    0.15





    $

    0.07





    NM



    NM





























    Weighted average common shares outstanding - assuming dilution





    46,773







    47,773







    47,703





    (2.1) %



    (1.9) %





























    Effective tax rate





    96

    %





    35

    %





    32

    %



    NM



    NM





























    SEGMENT INFORMATION:























































    Revenue:



























    Reservoir Description



    $

    80,897





    $

    86,793





    $

    84,236





    (6.8) %



    (4.0) %

    Production Enhancement





    42,688







    42,444







    45,401





    0.6 %



    (6.0) %

    Consolidated



    $

    123,585





    $

    129,237





    $

    129,637





    (4.4) %



    (4.7) %





























    Operating income:



























    Reservoir Description



    $

    2,339





    $

    16,643





    $

    6,892





    (85.9) %



    (66.1) %

    Production Enhancement





    1,503







    (2,597)







    1,576





    NM



    (4.6) %

    Corporate and Other





    575







    128







    103





    NM



    NM

    Consolidated



    $

    4,417





    $

    14,174





    $

    8,571





    (68.8) %



    (48.5) %





























    "NM" means not meaningful



























     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands)

    (Unaudited) 

     

















    % Variance

    ASSETS:



    March 31,

    2025





    December 31,

    2024





    vs. Q4-24



















    Cash and cash equivalents



    $

    22,107





    $

    19,157





    15.4 %

    Accounts receivable, net





    117,031







    111,761





    4.7 %

    Inventories





    59,031







    59,402





    (0.6) %

    Other current assets





    30,599







    36,286





    (15.7) %

    Total current assets





    228,768







    226,606





    1.0 %



















    Property, plant and equipment, net





    97,943







    97,063





    0.9 %

    Right of use assets





    57,490







    56,488





    1.8 %

    Intangibles, goodwill and other long-term assets, net





    207,318







    210,249





    (1.4) %

    Total assets



    $

    591,519





    $

    590,406





    0.2 %



















    LIABILITIES AND EQUITY:



































    Accounts payable



    $

    38,497





    $

    34,549





    11.4 %

    Short-term operating lease liabilities





    11,654







    10,690





    9.0 %

    Other current liabilities





    53,576







    52,347





    2.3 %

    Total current liabilities





    103,727







    97,586





    6.3 %



















    Long-term debt, net





    124,367







    126,111





    (1.4) %

    Long-term operating lease liabilities





    43,981







    43,343





    1.5 %

    Other long-term liabilities





    60,088







    65,630





    (8.4) %



















    Total equity





    259,356







    257,736





    0.6 %

    Total liabilities and equity



    $

    591,519





    $

    590,406





    0.2 %

     

    CORE LABORATORIES INC. & SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     





    Three Months Ended March 31,







    2025





    2024



    CASH FLOWS FROM OPERATING ACTIVITIES:













    Net income



    $

    69





    $

    3,490



    Adjustments to reconcile net income to net cash provided by operating activities:













    Stock-based compensation





    4,159







    4,820



    Depreciation and amortization





    3,717







    3,843



    Deferred income taxes





    (1,817)







    2,827



    Accounts receivable





    (5,938)







    (6,290)



    Inventories





    (272)







    991



    Accounts payable





    2,971







    (551)



    Other adjustments to net income





    3,771







    (3,600)



    Net cash provided by operating activities





    6,660







    5,530

















    CASH FLOWS FROM INVESTING ACTIVITIES:













    Capital expenditures - operations





    (2,785)







    (3,052)



    Capital expenditures - rebuilding of Aberdeen facility





    (794)







    —



    Net proceeds from insurance recovery





    3,121







    —



    Net proceeds on life insurance policies





    —







    805



    Other investing activities





    1,230







    590



    Net cash provided by (used in) investing activities





    772







    (1,657)

















    CASH FLOWS FROM FINANCING ACTIVITIES:













    Repayment of long-term debt





    (15,000)







    (17,000)



    Proceeds from long-term debt





    13,000







    14,000



    Dividends paid





    (469)







    (468)



    Repurchase of common shares





    (2,022)







    (44)



    Equity related transaction costs and other financing activities





    9







    (568)



    Net cash used in financing activities





    (4,482)







    (4,080)

















    NET CHANGE IN CASH AND CASH EQUIVALENTS





    2,950







    (207)



    CASH AND CASH EQUIVALENTS, beginning of period





    19,157







    15,120



    CASH AND CASH EQUIVALENTS, end of period



    $

    22,107





    $

    14,913



     

    Non-GAAP Information

    Management believes that the exclusion of certain income and expenses enables it to evaluate more effectively the Company's operations period-over-period and to identify operating trends that could otherwise be masked by the excluded Items. For this reason, management uses certain non-GAAP measures that exclude these Items and believes that this presentation provides a clearer comparison with the results reported in prior periods. The non-GAAP financial measures should be considered in addition to, and not as a substitute for, the financial results prepared in accordance with GAAP, as more fully discussed in the Company's financial statements and filings with the Securities and Exchange Commission.

    Reconciliation of Operating Income, Net Income (Loss) and Diluted Earnings (Loss) Per Share Attributable to Core Laboratories Inc.

    (In thousands, except per share data)

    (Unaudited)

     





    Operating Income







    Three Months Ended







    March 31,

    2025





    December 31,

    2024





    March 31,

    2024



    GAAP reported



    $

    4,417





    $

    14,174





    $

    8,571



    Stock compensation (1)





    3,505







    (771)







    3,458



    Inventory and asset write-downs, lease abandonment and severance (2)





    3,416







    4,115







    2,633



    Gain on insurance recovery (3)





    —







    (2,572)







    —



    Foreign exchange losses (gains)





    480







    761







    285



    Excluding specific items



    $

    11,818





    $

    15,707





    $

    14,947



     











    Net Income (Loss) Attributable to Core Laboratories Inc.





    Three Months Ended





    March 31,

    2025



    December 31,

    2024



    March 31,

    2024

    GAAP reported



    $(154)



    $7,403



    $3,220

    Stock compensation (1)



    2,629



    (617)



    2,766

    Inventory and asset write-downs, lease abandonment and severance (2)



    2,562



    3,292



    2,106

    Gain on insurance recovery (3)



    —



    (2,058)



    —

    Foreign exchange losses (gains)



    360



    610



    229

    Effect of higher (lower) tax rate (4)



    1,292



    1,766



    628

    Excluding specific items



    $6,689



    $10,396



    $8,949









     





    Diluted Earnings (Loss) Per Share Attributable to Core Laboratories Inc.







    Three Months Ended







    March 31,

    2025





    December 31,

    2024





    March 31,

    2024



    GAAP reported



    $

    —





    $

    0.15





    $

    0.07



    Stock compensation (1)





    0.05







    (0.01)







    0.06



    Inventory and asset write-downs, lease abandonment and severance (2)





    0.05







    0.07







    0.04



    Gain on insurance recovery (3)





    —







    (0.04)







    —



    Foreign exchange losses (gains)





    0.01







    0.01







    0.01



    Effect of higher (lower) tax rate (4)





    0.03







    0.04







    0.01



    Excluding specific items



    $

    0.14





    $

    0.22





    $

    0.19























    (1) Three months ended March 31, 2024 and 2025 includes the acceleration of stock compensation expense associated with employees reaching eligible retirement age. Three months ended December 31, 2024  includes reversals of stock compensation expense previously recognized due to a change in probability of performance condition for certain executive's share awards.



    (2) Three months ended March 31, 2024 and 2025 and three months ended December 31, 2024  includes severance costs, the write-down of inventory, right of use assets and leasehold improvements, and other exit costs associated with consolidation of certain facilities.



    (3) Three months ended December 31, 2024 Includes gain on insurance recovery associated with the fire at the Aberdeen, U.K. facility.



    (4) Three months ended March 31, 2024 and three months ended December 31, 2024 reflects tax expense at a normalized rate of 20%. Three months ended March 31, 2025 reflects tax expense at a normalized rate of 25%.



     

    Segment Information

    (In thousands)

    (Unaudited)

     





    Operating Income







    Three Months Ended March 31, 2025







    Reservoir

    Description





    Production

    Enhancement





    Corporate and

    Other



    GAAP reported



    $

    2,339





    $

    1,503





    $

    575



    Stock compensation





    2,360







    1,145







    —



    Inventory and asset write-downs, lease abandonment and severance





    2,869







    547









    Foreign exchange losses (gains)





    188







    242







    50



    Excluding specific items



    $

    7,756





    $

    3,437





    $

    625



     

    Return on Invested Capital

    Return on Invested Capital ("ROIC") is presented based on management's belief that this non-GAAP measure is useful information to investors and management when comparing profitability and the efficiency with which capital has been employed over time relative to other companies. The Board has established an internal metric to demonstrate ROIC performance relative to the oilfield service companies listed as Core's Comp Group by Bloomberg. ROIC is not a measure of financial performance under GAAP and should not be considered as an alternative to net income.

    ROIC of 8.3% is defined by Bloomberg as Net Operating Profit After Tax ("NOPAT") of $33.6 million divided by Average Total Invested Capital ("Average TIC") of $402.2 million, where NOPAT is defined as GAAP net income before non-controlling interest plus the sum of income tax expense, interest expense, and pension expense, less pension service cost and tax effect on income before interest and tax expense for the last four quarters. Average TIC is defined as the average of beginning and ending periods' GAAP stockholders' equity, plus the sum of net long-term debt, lease liabilities, allowance for credit losses, net of deferred taxes and income taxes payable.

    Free Cash Flow

    Core uses the non-GAAP financial measure of free cash flow to evaluate its cash flows and results of operations. Free cash flow is defined as net cash provided by operating activities (which is the most directly comparable GAAP measure) less cash paid for capital expenditures - operations. Management believes that free cash flow provides useful information to investors regarding the cash available in the period in excess of Core's needs to fund its capital expenditures and operating activities. Free cash flow is not a measure of operating performance under GAAP and should not be considered in isolation nor construed as an alternative to operating income, net income, or cash flows from operating, investing, or financing activities, each as determined in accordance with GAAP. Free cash does not represent residual cash available for distribution because Core may have other non-discretionary expenditures that are not deducted from the measure. Moreover, since free cash flow is not a measure determined in accordance with GAAP and thus is susceptible to varying interpretations and calculations, free cash flow as presented may not be comparable to similarly titled measures presented by other companies.

    Computation of Free Cash Flow

    (In thousands)

    (Unaudited)

     





    Three Months Ended









    March 31, 2025





    Net cash provided by operating activities



    $

    6,660





    Capital expenditures - operations





    (2,785)





    Free cash flow



    $

    3,875





     

    Core Laboratories Inc (PRNewsfoto/Core Laboratories)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/core-lab-reports-first-quarter-2025-results-302436442.html

    SOURCE Core Laboratories Inc

    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Core Labs upgraded by Citigroup with a new price target

      Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

      3/12/25 7:22:24 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by Citigroup with a new price target

      Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

      6/30/23 7:19:53 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by BofA Securities with a new price target

      BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

      4/18/23 9:05:50 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:55:21 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:53:25 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      4/2/25 2:40:47 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CLB
    Financials

    Live finance-specific insights

    See more
    • CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA

      HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East. The Company's new analytical laboratory is equipped with advanced proprietary instrumentation designed to provide comprehensive core and fluid analysis services tailored to unconventional reservoirs. By bringing Core Lab's cutting-edge technologies t

      5/7/25 12:53:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

      FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

      1/29/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      6/12/23 4:02:30 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 4:08:12 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 9:10:51 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Core Laboratories Inc.

      10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/25/25 6:36:23 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/23/25 4:41:18 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form DEFA14A filed by Core Laboratories Inc.

      DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      3/31/25 4:59:20 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy